The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...
Medicare to negotiate prices for blockbuster drugs like Ozempic and Wegovy, potentially saving enrollees millions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback